Having trouble viewing this email? Click here!

News September 2014 QPS360 Newsletter - 9th Edition Corporate QPS Launches New Responsive Website! Neuropharmacology Neuronal Plasticity An Inducible Murine Model of Tau Phosphorylation α-Synuclein A53T Mice Present with Progressive Motor Decline DMPK QPS/THI Summer Webinar Series - Quantitative Whole-Body Autoradiography (QWBA) in Drug Discovery and Development QPS/THI Summer Webinar Series - Predicting Hepatoxic Potential of NCE's in Patients QPS/THI Summer Webinar Series - Interpreting the Enzyme Induction EMA and FDA Guidance for Industry Toxicology QPS Hepatic Biosciences scientists co-author Article on the interpretation of the pre-clinical liver effects seen with a NCE Bioanalysis New Drug Assays added to the QPS Global Assay Database Translational Medicine Development and Validation of Cell-Based Neutralizing Anti-Adalimumab Antibody Detection Methods for Adalimumab Biosimilar Program New Biomarker Assays at QPS Are Paving the Way for Personalized Medicine Early Stage Clinical Doug Kalman, Director of QPS MRA's Nutrition/Endocrinology Department publishes Article on the Amino Acid Composition of Concentrated Protein Powders Paul Lehman, QPS' Vice President and Head of Dermal and Transdermal Research publishes Article on Assessing the Relative Bioavailability of Topical Clobetasol Propionate Products Late Stage Clinical QPS Respiratory & Allergy News Fresh from the Pipeline The Latest Original New FDA and EMA Drug Approvals    Posters - You Talk CAA in Mutant AD Mice - A Comparative Study to Human AD Cases    QPS Tube QPS/THI Summer Webinar Series    See You @ 19th North American Regional ISSX Meeting and 29th JSSX Annual Meeting October 19 - 23, 2014 San Francisco, CA, USA